AbCellera Biologics Inc. · NASDAQ:ABCL

Booth Andrew bought 8,600 AbCellera Biologics Inc. shares (Form 4)

Traded Nov 13, 2026 · Filed Nov 13, 2026

On Nov 13, 2026, Booth Andrew (Chief Financial Officer) bought 8,600 AbCellera Biologics Inc. shares at US$11.33 for US$97,438, leaving 491,400 shares. Filed Nov 13, 2026 (Form 4).

Bought
8,600 shares
Price
US$11.33
Value
US$97,438
Holding after
491,400 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 13, 2026Common SharesBuy8,600US$11.33491,400Direct

Source

Download original · View original at SEC

Related